WallStSmart

Heartbeam Inc (BEAT)vsBrightSpring Health Services, Inc. Common Stock (BTSG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BTSG leads profitability with a 2.5% profit margin vs 0.0%. BTSG earns a higher WallStSmart Score of 55/100 (C).

BEAT

Avoid

21

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 5.3
Piotroski: 2/9Altman Z: -29.61

BTSG

Buy

55

out of 100

Grade: C

Growth: 8.7Profit: 5.0Value: 4.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.59

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BEAT1 strengths · Avg: 8.0/10
Price/BookValuation
2.7x8/10

Reasonable price relative to book value

BTSG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
196.6%10/10

Earnings expanding 196.6% YoY

Revenue GrowthGrowth
23.0%8/10

Revenue surging 23.0% year-over-year

Areas to Watch

BEAT4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$22.90M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

BTSG4 concerns · Avg: 2.8/10
Profit MarginProfitability
2.5%3/10

2.5% margin — thin

Operating MarginProfitability
3.4%3/10

Operating margin of 3.4%

Debt/EquityHealth
1.173/10

Elevated debt levels

P/E RatioValuation
54.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : BEAT

The strongest argument for BEAT centers on Price/Book.

Bull Case : BTSG

The strongest argument for BTSG centers on EPS Growth, Revenue Growth. Revenue growth of 23.0% demonstrates continued momentum.

Bear Case : BEAT

The primary concerns for BEAT are Revenue Growth, EPS Growth, Market Cap.

Bear Case : BTSG

The primary concerns for BTSG are Profit Margin, Operating Margin, Debt/Equity. A P/E of 54.2x leaves little room for execution misses. Thin 2.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

BEAT profiles as a value stock while BTSG is a growth play — different risk/reward profiles.

BTSG carries more volatility with a beta of 1.85 — expect wider price swings.

BTSG is growing revenue faster at 23.0% — sustainability is the question.

BTSG generates stronger free cash flow (15M), providing more financial flexibility.

Bottom Line

BTSG scores higher overall (55/100 vs 21/100) and 23.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Heartbeam Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.

Visit Website →

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, focusing on diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation support. The company prioritizes personalized, high-quality care, facilitated by a dedicated and skilled workforce that significantly improves patient outcomes and quality of life. With robust investments in innovative technologies and a strong commitment to value-based care, BrightSpring is well-positioned to capitalize on growth opportunities within the dynamic healthcare landscape, highlighting its potential for sustainable, long-term success.

Visit Website →

Want to dig deeper into these stocks?